Self-targeting antibodies typically associated with a scarring disease called scleroderma are commonly found in people with Sjögren’s syndrome…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Steroid injections into the spine — similar to the epidural injections often given during childbirth — were effective in controlling…
No connection is evident between exposure to the dental amalgam used to fill cavities and the risk of developing…
Telitacicept (RC18), an experimental therapy being developed by RemeGen, significantly eased disease activity in people with primary…
Combining the anti-inflammatory medicines hydrocortisone and ciclosporin A could help ease eye symptoms in people with Sjögren’s syndrome, according…
A clinical trial at the University of Texas Southwestern Medical Center in Dallas is currently recruiting people with autoimmune diseases,…
Note: This story was updated Dec. 21, 2021, to note that Sjögren’s syndrome is not a rare disease, being…
Mesenchymal stem cells (MSCs), traditionally found in the bone marrow of adults, may help treat Sjögren’s syndrome by improving…
The Sjögren’s Foundation has given it 2021 Outstanding Abstract Award to two scientists who presented new research about…
The Sjögren’s Foundation, a nonprofit health organization focused on increasing research, education, and awareness about Sjögren’s syndrome, has…